Drug Allergy Market is expected to reach USD 4764.0 million by 2023

Drug allergy market info: by type (immunologic, nonimmunologic, and others), diagnosis (skin tests, blood tests,), by treatment, by end user-forecast till 2023

PUNE, MAHARASHTRA, INDIA, August 22, 2017 /EINPresswire.com/ -- Market Research Future Publish a New Report on - “Drug Allergy Market Research Report - Global forecast till 2023”

Exclusive Summery About Report:
The global drug allergy market is growing moderately and it is expected to grow with the same pace over the forecast period 2017-2018. Increasing prevalence of drug allergies and funding for research & development of the new drugs drive the global market.
The global market of drug allergy was around USD 3363.2 million in 2016 and is expected to reach USD 4764.0 million by 2023 at a projected CAGR of 5.1%.

Taste the market data and market information presented through more than 56 market data tables and figures spread over 84 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Drug allergy Market Research Report–Global Forecast to 2023.”

Drug Allergy Market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• AstraZeneca (UK),
• Bayer (US),
• Circassia (US),
• HAL Allergy Group (the Netherlands)
• Johnson & Johnson Services, Inc. (US),
• MAGNA Pharmaceuticals, Inc. (US),
• Stallergenes Greer (UK)

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/4033

Regional Analysis
The global drug allergy market is consist of four regions: America, Europe, Asia Pacific, and the Middle East & Africa.

Increasing funding for R&D, and ongoing clinical trials of various drugs are driving the growth for the America drug allergy market. The Americas market is consist of North America and Latin America. The drug allergy is one of the most common types of allergy in North America, especially, in the US. The Latin American market holds the least market share; however, this market is expected to grow significantly during the forecast period 2017-2023.

Europe drug allergy market is the second largest market in the globe and growing significantly. According to European Academy of Allergy and Clinical Immunology (EAACI), around 2.6% hospitalization happens due to adverse drug effects while the prevalence of drug allergy in the hospitalized patients is around 10% in the Europe.

Growing awareness about various drug allergies, improving drug standards, and changing healthcare practices are leading the growth of the market in Asia Pacific.

The Middle East & Africa has one of the highest prevalence rate of different allergies, however, lack of awareness about drug allergies, their causes, symptoms, and t available treatments slow down the growth of the market in this region.

If you have any special requirements, please let us know and we will offer you the report as you want.

For further information on this report, visit @ https://www.marketresearchfuture.com/reports/drug-allergy-market-4033

Segmentation
The global drug allergy market is segmented on the basis of type, which comprises of immunologic, non-immunologic, and others. Immunologic is sub-segmented into type I reaction, type II reaction, type III reaction, type IV reaction, and others. Non-immunologic allergy is further sub-segmented into predictable, unpredictable, and others. Predictable is sub-segmented into pharmacologic side effect, secondary pharmacologic side effect, drug toxicity, drug-drug interactions, drug overdose, and others. Unpredictable segment is further segmented into pseudoallergic, idiosyncratic, intolerance, and others.

On the basis of diagnosis, the market is segmented into skin tests, blood tests, patch test, and others. Skin test is further segmented into prick or scratch test, intradermal test, and others.

On the basis of treatments, the market has been segmented into antihistamines, corticosteroids, treatment of anaphylaxis, withdrawal of the drug, and others. Antihistamines is further sub-segmented into azelastine eyedrops, azelastine nasal sprays, carbinoxamine , cyproheptadine, desloratadine, diphenhydramine, emedastine eyedrops, hydroxyzine, levocabastine eyedrops, levocabastine oral, and others. Corticosteroids is sub-segmented into topical steroids, inhaled steroids, and others. Inhaled steroids is further segmented into flunisolide, fluticasone furoate, fluticasone propionate, triamcinolone acetonide, beclomethasone dipropionate, budesonide, and others.

On the basis of end user, it is segmented into hospital & clinics, medical research centers, academic institutes, and others.

Table of Content
1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
………Continued

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact
Akash Anand,
Market Research Future
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

Akash Anand
Market Research Future
+1-646-845-9349 (US) / +44 208 133 9349 (UK)
email us here